Wolfe Research initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $19 price target After its IPO in September 2024, ...

The only gap in their line-up is bowlers with the ability to hit sixes, and that's something they might have to live with for ...

The long-run expected return for the Global Market Index remained above 7% for a third straight month in January, ticking ...

Prashant Khemka, Founder of White Oak Capital Management, anticipates a shift in performance between cyclical and defensive ...

Baron Fifth Avenue Growth Fund increased during the fourth quarter of 2024, outperforming its benchmark, the Russell 1000 Growth Index.

Prashant Jain, Founder & CIO of 3P Investment Managers, suggests that India's insignificant manufacturing sector and small ...